focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: K3 director linked to purchase, Diurnal exec sells shares into ISA

Mon, 09th May 2022 14:01

(Sharecast News) - Software company K3 Business Technology was at the top of the list of buys on Monday, after Kestrel Partners spent more than £40k on its shares.

The AIM-traded firm said Kestrel Partners, on behalf of its discretionary clients, bought 27,129 shares for 150p each, spending a total of £40,693.50.

Its non-executive director Oliver Scott is a partner of, and holds a beneficial interest in Kestrel, and is also a shareholder in one of Kestrel's clients, Kestrel Opportunities, and so has a beneficial interest in Kestrel Opportunities' entire legal holding in the company.

Following the purchase, K3 said Kestrel Opportunities held 8,515,879 of its shares, and other clients of Kestrel in which Scott had no beneficial interest held 2,775,101 shares.

In total, Kestrel indirectly held voting rights over 11,290,980 of K3's shares, representing 25.24% percent of its issued share capital.

On the selling side of the ledger, specialty pharmaceutical company Diurnal Group disclosed a sale worth over £40k made by its chief scientific officer.

The AIM-traded firm said Richard Ross sold 312,000 shares for 13p each, while his and his wife's individual savings accounts (ISAs) purchased 153,500 and 153,500 shares, respectively, at a price of 13.01p each.

Following the transactions, the total beneficial interest of Richard Ross and his connected parties was 2,257,155 shares, representing 1.33% of Diurnal's total voting rights as of 9 May.

Top Director Buys

K3 Business Technology Group (KBT)

Director name: Scott,Oliver Rupert Andrew

Amount purchased: 27,129 @ 150.00p

Value: £40,693.50

Diurnal Group (DNL)

Director name: Ross,Richard

Amount purchased: 153,500 @ 13.01p

Value: £19,970.35

Diurnal Group (DNL)

Director name: Ross,Richard

Amount purchased: 153,500 @ 13.01p

Value: £19,970.35

Discoverie Group (DSCV)

Director name: Watson ,Clive

Amount purchased: 2,875 @ 690.00p

Value: £19,837.50

Henderson Smaller Companies Inv Trust (HSL)

Director name: Carter,Kevin

Amount purchased: 1,500 @ 868.36p

Value: £13,025.39

Target Healthcare Reit Ltd (THRL)

Director name: Fyfe,Alison

Amount purchased: 10,000 @ 109.80p

Value: £10,980.00

Mgc Pharmaceuticals Limited Npv (di) (MXC)

Director name: Zomer,Roby

Amount purchased: 819,672 @ 1.30p

Value: £10,655.74

Parity Group (PTY)

Director name: Johns,Mike

Amount purchased: 139,082 @ 7.19p

Value: £10,000.00

Mondi (MNDI)

Director name: Strank,Angela

Amount purchased: 628 @ 1,579.95p

Value: £9,922.08

Henderson Smaller Companies Inv Trust (HSL)

Director name: Freer,Penelope Anne

Amount purchased: 1,000 @ 878.92p

Value: £8,789.20

Reach (RCH)

Director name: Panayi,Barry

Amount purchased: 3,979 @ 124.72p

Value: £4,962.77

Capita (CPI)

Director name: Murphy,Joseph

Amount purchased: 643 @ 26.83p

Value: £172.52

Capita (CPI)

Director name: Lewis,Jonathan (Jon)

Amount purchased: 643 @ 26.83p

Value: £172.52

Capita (CPI)

Director name: Weller,Tim

Amount purchased: 643 @ 26.83p

Value: £172.52

Assura (AGR)

Director name: Cottam,Jayne

Amount purchased: 228 @ 66.16p

Value: £150.84

Assura (AGR)

Director name: Murphy,Jonathan

Amount purchased: 228 @ 66.16p

Value: £150.84

Top Director Sells

Rolls-royce Holdings (RR.)

Director name: East,Warren

Amount sold: 210,515 @ 83.78p

Value: £176,369.47

Diurnal Group (DNL)

Director name: Ross,Richard

Amount sold: 312,000 @ 13.00p

Value: £40,560.00

More News
11 Oct 2021 19:51

TRADING UPDATES: Baron Oil boosts P2478 stake amid Upland farmout pact

TRADING UPDATES: Baron Oil boosts P2478 stake amid Upland farmout pact

Read more
14 Sep 2021 17:46

TRADING UPDATES: Strong annual results from Springfield, Fiske

TRADING UPDATES: Strong annual results from Springfield, Fiske

Read more
13 Sep 2021 20:23

IN BRIEF: Diurnal's Efmody adrenal treatment launches in UK

IN BRIEF: Diurnal's Efmody adrenal treatment launches in UK

Read more
7 Sep 2021 16:25

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Sep 2021 19:34

TRADING UPDATES: Power Metal hits "bullseye"; Instem makes acquisition

TRADING UPDATES: Power Metal hits "bullseye"; Instem makes acquisition

Read more
28 Jul 2021 18:07

TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident

TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident

Read more
12 Jul 2021 10:10

Diurnal agrees special protocol with FDA for Chronocort study

(Sharecast News) - Specialty pharmaceutical company Diurnal announced on Monday that the US Food and Drug Administration (FDA) has agreed a special protocol assessment (SPA) for 'Chronocort', or modified-release hydrocortisone, for the design, endpoints and statistical analysis approach of a pivotal study of the product, for the treatment for congenital adrenal hyperplasia (CAH).

Read more
2 Jul 2021 10:02

Diurnal gets UK approval for 'Efmody' treatment

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Friday that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorisation for 'Efmody', or hydrocortisone modified-release hard capsules, as treatment for adult and adolescent patients with the rare congenital adrenal hyperplasia (CAH) condition.

Read more
2 Jul 2021 10:01

Diurnal gets UK approval for Efmody drug following EU authorisation

Diurnal gets UK approval for Efmody drug following EU authorisation

Read more
29 Jun 2021 17:10

TRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan

TRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan

Read more
1 Jun 2021 20:24

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

Read more
28 May 2021 19:41

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

Read more
12 May 2021 15:30

IN BRIEF: Diurnal extends Citrine licensing deal for Efmody in China

IN BRIEF: Diurnal extends Citrine licensing deal for Efmody in China

Read more
23 Apr 2021 12:56

IN BRIEF: Diurnal gets another patent for adrenal insufficiency asset

IN BRIEF: Diurnal gets another patent for adrenal insufficiency asset

Read more
23 Apr 2021 10:31

Diurnal granted European patent for Alkindi

(Sharecast News) - Hormonal disease-focussed speciality pharmaceutical company Diurnal Group announced the grant of a patent for 'Alkindi', or hydrocortisone granules in capsules for opening, by the European Patent Office on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.